Could we have known earlier? The answer, in many cases, is yes.
In India, where sickle cell disease quietly reshapes the lives of thousands of families, medical experts are calling for a small but consequential shift in how couples approach the beginning of life: test before you conceive. The condition hides in carriers who feel nothing, only revealing itself when two unknowing partners bring a child into the world who may inherit a lifetime of pain, organ damage, and medical crisis. A simple blood test, taken before pregnancy, offers couples the rare gift of foresight — the chance to make one of life's most profound decisions with full knowledge rather than regret.
- Thousands of Indian families discover their child has sickle cell disease only after illness strikes, arriving at a question that cannot be undone: could we have known?
- The disease's cruelest feature is its invisibility in carriers — people with one copy of the gene live healthy, ordinary lives, unaware they carry a risk that doubles when two carriers become parents.
- Medical specialists across Bengaluru and Kerala are urging couples to include hemoglobin electrophoresis — a straightforward blood test — in routine family planning, before conception rather than after crisis.
- When both partners test positive, genetic counseling can map out their options, and early diagnosis of affected children dramatically reduces hospitalizations, organ damage, and long-term complications.
- India bears one of the world's heaviest sickle cell burdens, and while national initiatives have made progress, preconception screening remains largely absent from the conversations most couples have when planning a family.
A couple planning a family thinks about schools, finances, and health insurance. What they rarely consider is whether they carry a hidden genetic risk capable of reshaping their child's entire life. In India, where sickle cell disease affects thousands of families, medical experts are now pushing a straightforward intervention: test before you conceive.
Sickle cell disease turns normally flexible red blood cells rigid and crescent-shaped, causing them to block blood vessels and deprive tissues of oxygen. The result is a lifetime of severe pain episodes, chronic anemia, organ damage, and repeated hospitalizations — beginning at birth and never relenting. Yet carriers of the gene — those with only one copy — feel nothing. Most live healthy lives without ever knowing. The danger surfaces when two carriers have a child together, who then faces a 25 percent chance of inheriting the full disease.
Dr. Rasmi Palassery of Ramaiah Memorial Hospital in Bengaluru notes that a blood test called hemoglobin electrophoresis can identify carrier status before pregnancy. Dr. Reshma Anegundi of Apollo Hospitals in Bangalore has seen families arrive at this knowledge too late, parents asking in the shadow of a sick child whether they could have known earlier. In most cases, the answer is yes.
Early diagnosis transforms outcomes. Children identified at birth can receive preventive care, vaccinations, and regular monitoring that reduce serious complications and emergency visits. Dr. Jenny Elizabeth George of Apollo Adlux Hospital in Kerala emphasizes that prior knowledge allows couples to seek genetic counseling and approach their choices with clarity rather than crisis.
India carries one of the world's largest sickle cell burdens, with high prevalence in tribal and central regions, though migration means the condition is no longer confined to specific communities. The goal of wider preconception screening is not to surround parenthood with anxiety — it is to offer couples information early enough to make decisions they feel genuinely prepared for, improving outcomes not only for individual families but for generations to come.
A couple sits down to plan their family. They think about schools, finances, health insurance. What they rarely think about is whether they carry a hidden genetic risk—one that could reshape their child's entire life. In India, where sickle cell disease affects thousands of families, that oversight is becoming harder to justify. Medical experts are now pushing a simple idea: test before you conceive.
Sickle cell disease is a blood disorder that rewires how oxygen moves through the body. Red blood cells, normally round and flexible, become rigid and crescent-shaped in people with the condition. These deformed cells jam up blood vessels, starving tissues of oxygen and triggering waves of severe pain, organ damage, chronic exhaustion, and a lifetime of medical crisis. The disease is present from birth and never leaves. Children born with it face repeated hospitalizations, damage to kidneys and lungs and heart, and a quality of life constrained by the body's own rebellion.
But here is the trap: you can carry the gene and feel nothing. Sickle cell trait—one copy of the altered gene instead of two—produces no symptoms. Most carriers live ordinary, healthy lives and never know they have it. The problem emerges when two carriers have a child together. That child faces a 25 percent chance of inheriting the full disease. Many Indian couples discover this fact only after a child falls ill, when the question becomes unbearable: could we have known?
Dr. Rasmi Palassery, a consultant in medical oncology at Ramaiah Memorial Hospital in Bengaluru, frames the issue plainly. Sickle cell disease transforms red blood cells and triggers chronic anemia, painful episodes, and serious complications. What people miss is that carriers exist in the shadows. A straightforward blood test called hemoglobin electrophoresis can identify who carries the gene. If both partners test positive, genetic counseling can walk them through their options and help them plan with full knowledge of what lies ahead.
Dr. Reshma Anegundi, a pathologist at Apollo Hospitals in Bangalore, has watched families arrive at this crossroads too late. "For many families, sickle cell disease enters the conversation only after a child falls ill," she says. "By then, parents are often asking: could we have known earlier? The answer, in many cases, is yes." At Apollo, awareness of preventive health is growing, but genetic screening remains absent from most couples' family planning conversations. A single test can reveal carrier status. When both parents carry the gene, that information becomes a map for understanding their children's risk and preparing for the medical care that may be needed.
Early diagnosis changes everything. Children identified at birth can receive preventive care, vaccinations, infection control, and regular monitoring that reduce serious complications. Timely intervention improves growth, development, and long-term outcomes while cutting emergency hospital visits. The screening itself is not complicated. What is missing is awareness that it matters.
India carries one of the world's largest burdens of sickle cell disease, with particularly high prevalence in tribal and central regions. But migration and demographic shifts mean the condition is no longer confined to specific communities. National initiatives have strengthened the country's response, but wider adoption of preconception and premarital testing could prevent more cases and enable earlier intervention. Dr. Jenny Elizabeth George, a hematology consultant at Apollo Adlux Hospital in Kerala, emphasizes that for couples planning to conceive, sickle cell testing is informative. If both carry the gene, there is a 25 percent likelihood their baby could inherit the disease. Prior knowledge allows couples to seek genetic counseling and understand all their choices.
The goal is not to create anxiety around parenthood. It is to give couples information early enough to make decisions they feel prepared for. A simple blood test taken before pregnancy has the potential to improve outcomes not only for individual families but for future generations by promoting timely intervention, informed decision-making, and better overall health. As India strengthens its focus on preventive healthcare, incorporating sickle cell screening into routine family planning could play an important role in reducing the disease burden.
Citas Notables
Sickle cell disease is an inherited blood disorder that changes the shape and function of red blood cells resulting in chronic anaemia, painful episodes and a range of serious health complications.— Dr. Rasmi Palassery, Consultant, Department of Medical Oncology, Ramaiah Memorial Hospital, Bengaluru
For many families, sickle cell disease enters the conversation only after a child falls ill. By then, parents are often asking a difficult question: Could we have known earlier? The answer, in many cases, is yes.— Dr. Reshma Anegundi, Lab Head and Consultant Pathologist, Apollo Hospitals, Bangalore
La Conversación del Hearth Otra perspectiva de la historia
Why does carrier status matter so much if carriers themselves feel fine?
Because two carriers having a child together creates a one-in-four chance that child inherits the full disease. The carriers are healthy. Their child might not be. That's the asymmetry that makes testing valuable.
But doesn't knowing you're a carrier create anxiety before you even try to conceive?
That's the fear, but the doctors I read push back on it. They say the anxiety comes later—when a child is born sick and parents realize they could have known. Early knowledge lets you plan with your eyes open, not in shock.
What exactly does the test involve?
A blood test called hemoglobin electrophoresis. Straightforward. It identifies whether you carry the sickle cell trait. If both partners test positive, genetic counseling helps you understand your options and what to expect.
Is this a problem only in certain communities in India?
It started that way—high prevalence in tribal and central regions. But migration has spread it. The condition is no longer confined to specific populations, which is why broader screening matters now.
What happens if a couple finds out they're both carriers?
They have choices. They can proceed with pregnancy knowing the risks and preparing for early diagnosis and care. They can explore other reproductive options. The point is they're making the choice informed, not blindsided.
Does early diagnosis actually change outcomes for children born with the disease?
Significantly. Children identified at birth get preventive care, vaccinations, infection control, regular monitoring. That reduces serious complications and improves growth and development. It cuts emergency hospital visits. The difference between knowing early and finding out when a child gets sick is substantial.